INSIGHTS ON CLINICAL TRIAL PARTNERING

• Optimizing The Path From First-In-Human To Proof-Of-Concept

  By collapsing the gaps between manufacturing and clinical trials and integrating these functions into a unified system, teams can adjust formulations in real-time and accelerate timelines.

• Turning Innovation Into Execution In CNS Trials

  SCOPE 2026 experts called for practical planning, iterative testing, and real‑world workflows in mental health research, highlighting mock visits, expanded roles, engagement, and psychedelic safety.

   

   

   

   

   

• Five Ways Site-Facing Technology Helps Sponsors And CROs

  Site-facing technology is presented as a crucial enabler of efficient trial execution, aligning site operations with sponsor timelines and objectives.

• Development And Manufacture Of A Highly Potent OSD Product

  Highly potent drug compounds require advanced containment and robust technical transfer protocols. CDMOs overcome challenges through meticulous testing, specialized tooling, and strong supplier relationships.

• Why The Regional Site Manager Is The Swiss Army Knife Of Clinical Trial Monitoring

  1/28/2025

  The Regional Site Manager (RSM) monitoring model eliminates numerous clinical trial risks by leveraging efficient, start-to-finish site management by a single, expert point of contact.

• Are You Paying Participants Enough? Your Top Questions Answered

  6/24/2025

  Explore key themes surrounding payments to clinical research participants in depth, with a particular focus on the role of participant compensation and best practices in payment logistics.

• Successful Regulatory Submission Via The Trifecta Of Awesomeness

  1/17/2025

  Three essential elements contribute to a repeatable, adaptable regulatory submission process: strategic planning, team engagement, and properly leveraging team experience.

• EACT: Eliminating The Financial Burden For Patients

  6/7/2024

  Explore the EACT project's resources at eactproject.org to help reduce financial barriers and enhance participation in clinical trials.

• Meeting Regulatory And Patient Needs By Improving Clinical Trial Access

  3/26/2026

  Learn how to mitigate regulatory risk and improve trial diversity by reducing site burden and leveraging integrated technology to reach U.S. patients in their own communities.